JRCT ID: jRCT2080223902
Registered date:15/05/2018
Basic Information
Recruitment status | terminated |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 12/11/2018 |
Target sample size | 117 |
Countries of recruitment | Japan,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Generic name etc : INN of investigational material : Paclitaxel Therapeutic category code : 424 Antineoplastic preparations extracted from plants Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety |
---|---|
Secondary Outcome | pharmacokinetics |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03411161,JapicCTI-183959 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
clinicaltrials.jpn@servier.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
clinicaltrials.jpn@servier.com | |
Affiliation |